X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiac & cardiovascular systems (16) 16
humans (16) 16
index medicus (16) 16
male (10) 10
aged (9) 9
female (9) 9
middle aged (9) 9
double-blind method (8) 8
platelet aggregation inhibitors - therapeutic use (7) 7
treatment outcome (7) 7
abridged index medicus (6) 6
acute coronary syndromes (6) 6
cardiovascular disease (6) 6
evacetrapib (6) 6
prasugrel hydrochloride (6) 6
cholesterol ester transfer proteins - antagonists & inhibitors (5) 5
clopidogrel (5) 5
hdl (5) 5
pharmacology & pharmacy (5) 5
research (5) 5
angioplasty, balloon, coronary - adverse effects (4) 4
artery-disease (4) 4
benzodiazepines - administration & dosage (4) 4
benzodiazepines - adverse effects (4) 4
cardiovascular diseases (4) 4
cholesterol (4) 4
cholesteryl ester transfer protein inhibitor (4) 4
drug therapy (4) 4
drug therapy, combination (4) 4
heart attacks (4) 4
hypercholesterolemia (4) 4
mortality (4) 4
myocardial infarction (4) 4
myocardial-infarction (4) 4
peripheral vascular disease (4) 4
piperazines - therapeutic use (4) 4
prasugrel (4) 4
stroke (4) 4
thiophenes - therapeutic use (4) 4
thrombosis - prevention & control (4) 4
aggregation (3) 3
analysis (3) 3
anticholesteremic agents - adverse effects (3) 3
aspirin (3) 3
aspirin-treated patients (3) 3
atherosclerosis (3) 3
blood pressure (3) 3
cardiac patients (3) 3
cardiology (3) 3
cardiovascular agents (3) 3
cholesterol, hdl - blood (3) 3
cholesterol, ldl - blood (3) 3
clinical trials (3) 3
diabetes mellitus (3) 3
diagnosis (3) 3
drug dosages (3) 3
drugs (3) 3
heart attack (3) 3
hemorrhage - chemically induced (3) 3
high-risk (3) 3
incidence (3) 3
medicine, general & internal (3) 3
piperazines - adverse effects (3) 3
piperazines - pharmacokinetics (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
platelet aggregation inhibitors - pharmacokinetics (3) 3
studies (3) 3
thiophenes - adverse effects (3) 3
thiophenes - pharmacokinetics (3) 3
thrombolytic therapy (3) 3
abciximab (2) 2
achieves greater (2) 2
acute coronary syndrome - drug therapy (2) 2
acute coronary syndrome - mortality (2) 2
acute coronary syndrome - therapy (2) 2
acute myocardial-infarction (2) 2
adult (2) 2
age factors (2) 2
agonists (2) 2
angina pectoris (2) 2
anticholesteremic agents - administration & dosage (2) 2
apolipoproteins (2) 2
benzodiazepines - therapeutic use (2) 2
biomarkers - blood (2) 2
blood platelets (2) 2
body weight (2) 2
cardiovascular (2) 2
cardiovascular diseases - drug therapy (2) 2
care and treatment (2) 2
cholesterol ester transfer proteins - metabolism (2) 2
cholesterol, hdl - drug effects (2) 2
cholesterol, ldl - drug effects (2) 2
clinical outcomes (2) 2
comparative analysis (2) 2
complications and side effects (2) 2
coronary disease - drug therapy (2) 2
coronary heart disease (2) 2
coronary-heart-disease (2) 2
cs-747 (2) 2
diabetes (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 20, pp. 1933 - 1942
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A14025 - A14025
BackgroundPotential benefits of pharmacological CETP inhibition are likely to reflect lowering of apoB-containing lipoproteins as opposed to HDL-C raising.... 
Journal Article
by Gerstein, Hertzel C and Colhoun, Helen M and Dagenais, Gilles and Dagenais, Gilles R and Diaz, Rafael and Diaz, Sarahy and Lakshmanan, Mark and Pais, Prem and Probstfield, Jeffrey and Riesmeyer, Jeffrey S and Riddle, Matthew C and Rydén, Lars and Xavier, Denis and Atisso, Charles Messan and Dyal, Leanne and Hall, Stephanie and Hall, Charles and Rao-Melacini, Purnima and Wong, Gloria and Avezum, Alvaro and Basile, Jan and Chung, Ming-Min and Chung, Namsik and Chung, Jin-Wook and Conget, Ignacio and Cushman, William C and Franek, Edward and Hancu, Nicolae and Hanefeld, Christoph and Hanefeld, Markolf and Holt, Shaun and Jansky, Petr and Keltai, Matyas and Keltai, Katalin and Lanas, Fernando and Leiter, Lawrence A and Lopez-Jaramillo, Patricio and Cardona Munoz, Ernesto German and Pirags, Valdis and Pogosova, Nana and Raubenheimer, Peter J and Shaw, Jonathan E and Sheu, Wayne H-H and Temelkova-Kurktschiev, Theodora and Abella, Mercedes and Alebuena, Andrea and Almagro, Sandra and Amoroso, Eduardo and Anadon, Paula and Andreu, Elizabeth and Aristimuño, Guillermo and Arzadun, Maria and Barbieri, Maria and Barcudi, Raul and Bartolacci, Ines and Bolobanich, Gabriel and Bordonava, Anselmo and Bustamante Labarta, Miguel and Bustos, Betina and Caccavo, Alberto and Camino, Alejandra and Cantero, Maria and Carignano, Maria and Cartasegna, Luis and Cipullo, Marcela and Commendatore, Víctor and Conosciuto, Victoria and Costamagna, Osvaldo and Crespo, Claudia and Cuello, Jose and Cuneo, Carlos and Cusimano, Sandra and Dean, Sofia and Dituro, Claudio and Dominguez, Andrea and Farah, Miguel and Fernandez, Alberto and Fernandez, Florencia and Ferrari, Adriana and Flammia, Patricia and Fuentealba, Jose and Gallardo, Karina Beatriz and Garcia, Mar and Garcia, Celso and Garcia, Maria and Garcia Duran, Ruben and Garrido, Marcelo and Gavicola, Rodolfo and Gerbaudo, Claudio and Gilli, Graciela and Giotto, Ana Paula and Godoy Bolzán, Pedro and Gomez Vilamajo, Oscar and Guerlloy, Fernando and Guridi, Cristian and Gutierrez Garrido, Narcisa and Hasbani, Eduardo and Hermida, Sonia and Hominal, Miguel and Hrabar, Adrian and ... and REWIND Investigators
The Lancet, ISSN 0140-6736, 07/2019, Volume 394, Issue 10193, pp. 121 - 130
Journal Article
Circulation Journal, ISSN 1346-9843, 2017
Background:Inhibition of cholesteryl ester transfer protein with evacetrapib may provide an additional treatment option for patients who do not reach their... 
Hypercholesterolemia | Evacetrapib | High-density lipoprotein cholesterol | Cholesteryl ester transfer protein inhibitor | Low-density lipoprotein cholesterol
Journal Article
Circulation Journal, ISSN 1346-9843, 2017
Background:Inhibition of cholesteryl ester transfer protein by evacetrapib when added to atorvastatin may provide an additional treatment option for patients... 
Low-density lipoprotein | Hypercholesterolemia | Evacetrapib | High-density lipoprotein | Cholesteryl ester transfer protein inhibitor
Journal Article
Circulation, ISSN 0009-7322, 11/2018, Volume 138, Issue Suppl_1 Suppl 1, pp. A12636 - A12636
BackgroundThe failure of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib was associated with off target increased plasma aldosterone levels... 
Journal Article
Circulation, ISSN 0009-7322, 11/2016, Volume 134, Issue Suppl_1 Suppl 1, pp. A20280 - A20280
BackgroundThe cholesteryl ester transfer protein (CETP) inhibitor, evacetrapib (Eva), did not reduce cardiovascular events in the ACCELERATE trial when added... 
Journal Article
Atherosclerosis, ISSN 0021-9150, 2017, Volume 261, pp. 12 - 18
Abstract Background and aims The optimal approaches to management of patients treated with moderate statin doses on lipid parameters are unknown. The... 
Cardiovascular | Clinical trials | CETP | Lipids | Cardiovascular disease | CARDIAC & CARDIOVASCULAR SYSTEMS | CORONARY EVENTS | SAFETY | PREVENTION | WOMEN | HDL | HIGH-RISK | MEN | PERIPHERAL VASCULAR DISEASE | PRAVASTATIN | EVACETRAPIB | Cholesterol Ester Transfer Proteins - antagonists & inhibitors | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | United States | Atorvastatin Calcium - administration & dosage | Humans | Middle Aged | Male | Dyslipidemias - blood | Time Factors | Lipids - blood | Atherosclerosis - diagnosis | Female | Drug Therapy, Combination | Atorvastatin Calcium - adverse effects | Dyslipidemias - diagnosis | Dyslipidemias - drug therapy | Atherosclerosis - drug therapy | Double-Blind Method | Ezetimibe - adverse effects | Inflammation Mediators - blood | Treatment Outcome | Ezetimibe - administration & dosage | Biomarkers - blood | Anticholesteremic Agents - adverse effects | Atherosclerosis - blood | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Anticholesteremic Agents - administration & dosage | Benzodiazepines - administration & dosage | Aged | Benzodiazepines - adverse effects | Cholesterol Ester Transfer Proteins - metabolism | Medicine, Experimental | Medical research | Medical colleges | Comparative analysis | Statins | Low density lipoproteins | Cardiac patients | Apolipoproteins | Cardiovascular agents | Index Medicus
Journal Article